Therefore, our study will provide new insights into the molecular function of the DSCAM-AS1/miR-137/Notch1 axis in the pathogenesis of CRC and highlight the potential of lncRNAs to act as new therapeutic targets in CRC. This evidence concerns the gene DSCAM and colorectal carcinoma.